Business news in brief

0 Comments | Philadelphia Inquirer, The, October, 2006

IN THE REGION GlaxoSmithKline to buy maker of Breathe Right strips GlaxoSmithKline P.L.C. said yesterday that it would buy CNS Inc., Minneapolis, maker of Breathe Right nasal strips. The British drug company, with a U.S. headquarters in Philadelphia, said the deal valued at $566 million gives it global products with potential for "pipeline innovation," meaning new products.

Other GlaxoSmithKline products include Tums, Aquafresh and Nicorette, in addition to prescription drugs.- Thomas Ginsberg Convention Center nets three contracts Two large organizations have signed contracts to hold three meetings at the Convention Center, the Philadelphia Convention and Visitors Bureau said. The Infectious Diseases Society of America will bring more than 5,000 physicians and scientists to...